POOLBEG PHARMA (UK) LIMITED – Trademark Portfolio
Entity Type: 99
POOLBEG PHARMA (UK) LIMITED holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include POOLBEG PHARMA.
Queen Mary Bioenterprises,
Innovation Centre, 42 New Road, London E1 2AX
Showing of trademarks Trademarks
Trademark Classifications
POOLBEG PHARMA (UK) LIMITED's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does POOLBEG PHARMA (UK) LIMITED have?
POOLBEG PHARMA (UK) LIMITED has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does POOLBEG PHARMA (UK) LIMITED file in?
POOLBEG PHARMA (UK) LIMITED files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.
What are POOLBEG PHARMA (UK) LIMITED's most well-known trademarks?
POOLBEG PHARMA (UK) LIMITED's registered trademark portfolio includes well-known marks such as POOLBEG PHARMA. These are among 2 currently registered trademarks in the portfolio.
What is POOLBEG PHARMA (UK) LIMITED's trademark registration success rate?
POOLBEG PHARMA (UK) LIMITED has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.